Ascierto PA, Mandala M, Ferrucci PF, Guidoboni M, et al. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial. J Clin Oncol 2022 Sep 1:JCO2102961. doi: 10.1200/JCO.21.02961.
PMID: 36049147